Table 2.
The correlation analysis between hsa_circ_103820 expression and clinicopathologic characteristics in lung cancer.
| Clinicopathologic characteristics | No. of patients | Hsa_circ_103820 | P value | |
|---|---|---|---|---|
| High | Low | |||
| Age (year) | ||||
| >60 | 12 | 5 (41.7%) | 7 (58.3%) | 0.612 |
| ≤60 | 8 | 3 (37.5%) | 5 (62.5%) | |
| Gender | ||||
| Male | 13 | 8 (61.5%) | 5 (38.5%) | 0.608 |
| Female | 7 | 4 (57.1%) | 3 (42.9%) | |
| Tumor size (cm) | ||||
| <3 | 11 | 7 (63.6%) | 4 (36.4%) | 0.185 |
| ≥3 | 9 | 3 (33.3%) | 6 (66.7%) | |
| Differentiation grade | ||||
| Well/moderately | 7 | 5 (71.4%) | 2 (28.6%) | 0.102 |
| Poorly/undifferentiated | 13 | 4 (30.8%) | 9 (69.2%) | |
| Invasion | ||||
| T0-T2 | 14 | 11 (78.6%) | 3 (21.4%) | 0.018* |
| T3-T4 | 6 | 1 (16.7%) | 5 (83.3%) | |
| Lymph node metastasis | ||||
| N0 | 16 | 13 (81.3%) | 3 (18.8%) | 0.061 |
| N1–N2 | 4 | 1 (25%) | 3 (75%) | |
| Distal metastasis | ||||
| M0 | 18 | 13 (72.2%) | 5 (27.8%) | 0.111 |
| M1 | 2 | 0 (0.0%) | 2 (100.0%) | |
| TNM stage | ||||
| 0 & I & II | 17 | 12 (70.6%) | 5 (29.4%) | 0.049* |
| III & IV | 3 | 0 (0%) | 3 (100.0%) | |
*P < 0.05, TNM stage: pathologic tumor, node, metastasis stage.